Combat Medical raises £2.6 million Series A to advance treatment of BCG unresponsive bladder cancer
Investment led by T&J Meyer Family Foundation, joined by Varia [...]
PINCH Announces Two Major New Contract Wins as Business Growth Continues Into 2026
London, UK, 09 March 2026: PINCH is proud to announce [...]
Centauri Therapeutics granted FDA QIDP status for CTX-187 treatment of Gram-negative bacterial infections
Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed [...]
Eppendorf introduces SpinPro® centrifuge series to streamline life science research
New Eppendorf SpinPro® 6 R centrifuge maximises workflow efficiency with [...]
Cytotrait secures £3M seed funding to address global food security and sustainable agriculture
Proprietary MOSS technology enables high-level, localised gene expression to overcome [...]
Mursla Bio Accelerates US Commercial Deployment of EvoLiver Through ABHI Programme
Provides structured US market access for EvoLiver FDA-designated liver cancer [...]
OBN Invites Life Science Leaders to Celebrate 20 Years of BioTrinity
Featuring keynotes from: Steve Bates, Executive Chair at the Office [...]
SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings
SPT Labtech to develop an automated sample preparation platform for [...]
SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel
Aurase Wound Gel shows 22x faster debridement and 7x faster [...]
Centauri Therapeutics extends Series A to £30M with £6M investment from AMR Action Fund to support progression of lead clinical candidate
Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead [...]